Desarda Tissue Technique vs Lichtenstein Technique for Primary Inguinal Hernia Repair
HP-tis
Randomized Controlled Trial Comparing the Desarda Tissue Technique With the Lichtenstein Technique in Primary Inguinal Hernia Repair
1 other identifier
interventional
478
1 country
1
Brief Summary
This study aims to evaluate whether a surgical technique (Desarda) is superior to the commonly used surgical technique (Lichtenstein) in inguinal hernia repair concerning the occurrence of postoperative complications. The Lichtenstein technique involves the use of a mesh, while the Desarda technique does not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2024
CompletedFirst Posted
Study publicly available on registry
October 21, 2024
CompletedStudy Start
First participant enrolled
March 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
June 24, 2025
June 1, 2025
2.7 years
October 18, 2024
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of Participants with Post-surgery Complications
Any of the following complications: ● Sensation of a foreign body that persists beyond 3 months after surgery, self-reported by the participant ● Seroma within the first 30 days after surgery, verified through physical examination by a surgeon ● Hematoma within the first 30 days after surgery, verified through physical examination by a surgeon ● Infection at the surgical site within the first 30 days after surgery, verified by a surgeon ● Severe postoperative pain (7 or higher on the visual analog scale \[VAS\]) within the first 30 days after surgery, self-reported by the participant ● Chronic postoperative pain (persisting more than three months after surgery), self-reported by the participant ● Persistent loss of skin sensitivity beyond 30 days after surgery, self-reported by the participant ● Limitation of normal activities at home, outside the home, or at work beyond 3 months after surgery, self-reported by the participant
3 months
Study Arms (2)
Desarda Technique
EXPERIMENTALPatients asigned to this arm will be treated with Desarda Technique
Lichtenstein Technique
ACTIVE COMPARATORPatients asigned to this arm will be treated with Lichtenstein Technique
Interventions
This technique prevent from using a mesh to surgical repair of a inguinal hernia
This technique implies using a mesh to surgical repair of a inguinal hernia
Eligibility Criteria
You may qualify if:
- Diagnosed with primary inguinal hernia.
- Body mass index below 31
- Indication for inguinal hernia repair via anterior approach, either as outpatient surgery (CMA) or elective admission.
- Legal capacity to provide informed consent.
You may not qualify if:
- Patients with a weak, thin, or divided external oblique aponeurosis.
- Participants diagnosed with any of the following conditions:
- Ongoing oncological disease
- Cirrhotic patients classified as Child B or higher
- Women who have previously undergone a cesarean section
- Cognitive or affective conditions that limit the ability to cooperate with the study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CSAPG
Sant Pere de Ribes, Barcelona, 08810, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Javier Errando, MD
CSAPG
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2024
First Posted
October 21, 2024
Study Start
March 26, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2030
Last Updated
June 24, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- After publication of main results of the study.
- Access Criteria
- IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).